CATHAY BIOTECH INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.27 CNY | +1.03% |
|
-2.82% | -14.02% |
| 29/04 | Cathay Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 15/04 | Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6% | MT |
ETFs positioned on Cathay Biotech Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.69% | 1 M€ | -14.72% | - | |
| 0.81% | 45 M€ | -15.05% | - | |
| 0.81% | 45 M€ | -15.11% | - | |
| 0.81% | 35 M€ | -13.53% | - | |
| 0.00% | 32 M€ | +4.30% | - |
Cathay Biotech Inc is a China-based company engaged in research, development, production and sales of biobased materials. The Company's primary products are biological long-chain dibasic acids and bio-based polyamide series, including lauric acid and brazilian acid, which are used in long-chain polyamides, fragrances, hot melt adhesives, lubricants, powder coatings and other areas. The Company sells its products to domestic and overseas markets.
Sector
Specialty Chemicals
Calendar
08/08/2024
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -14.02% | 379.2Cr | |
| +13.72% | 2.84TCr | |
| +11.79% | 178.75Cr | |
| -10.77% | 64Cr | |
| -27.39% | 39Cr | |
| -81.65% | 22Cr | |
| -17.50% | 11Cr |
- Stock Market
- Equities
- 688065 Stock
- Funds and ETFs Cathay Biotech Inc.
